Cargando…
Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer
IMPORTANCE: Among patients with esophagogastric cancers, only individuals who present with known features of heritable cancer syndromes are referred for genetic testing. Broader testing might identify additional patients with germline alterations. OBJECTIVES: To examine the prevalence of likely path...
Autores principales: | Ku, Geoffrey Y., Kemel, Yelena, Maron, Steve B., Chou, Joanne F., Ravichandran, Vignesh, Shameer, Zarina, Maio, Anna, Won, Elizabeth S., Kelsen, David P., Ilson, David H., Capanu, Marinela, Strong, Vivian E., Molena, Daniela, Sihag, Smita, Jones, David R., Coit, Daniel G., Tuvy, Yaelle, Cowie, Kendall, Solit, David B., Schultz, Nikolaus, Hechtman, Jaclyn F., Offit, Kenneth, Joseph, Vijai, Mandelker, Diana, Janjigian, Yelena Y., Stadler, Zsofia K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276088/ https://www.ncbi.nlm.nih.gov/pubmed/34251444 http://dx.doi.org/10.1001/jamanetworkopen.2021.14753 |
Ejemplares similares
-
Perioperative versus total neoadjuvant chemotherapy in gastric cancer
por: Yang, Jessica, et al.
Publicado: (2023) -
Targeting EGFR in Esophagogastric Cancer
por: Maron, Steven B., et al.
Publicado: (2020) -
Towards Automation of Germline Variant Curation in Clinical Cancer Genetics
por: Ravichandran, Vignesh, et al.
Publicado: (2019) -
Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma
por: Tsai, Charlton, et al.
Publicado: (2022) -
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer
por: Maron, Steven B., et al.
Publicado: (2023)